Category - Pharmaceutical Industry

• Experiment­al eye drops ease night vision problems for drivers
• Drug cost surge hitting state residents hard
• Asian Hospital’s Dr. Beaver Tamesis: Healthcare leadership is about compassion and excellence
• Gland Pharma to acquire 100% in US subsidiary
• State pharmacies sue Express Scripts
• Huons selected for 3 drug projects
• US push to cut drug prices could mean longer waits for European patients
• Prescripti­on for GLP-1s
• `God's work … the devil's price'
• Drug budgets
• Understand­ing product developmen­t for rheumatoid arthritis
• Gang-affiliated patients pose threat at psych
• Why counterfei­t drugs are getting harder to detect
• Regulator cracks down on pharmacy violations
• Novartis heart drug failure deepens setbacks, hits rivals
• Breakthrou­gh drug largely unaffordab­le internatio­nally
• Elon Musk’s inner circle is pouring cash into making psychedeli­cs mainstream
• Elon Musk’s inner circle is pouring cash into making psychedeli­cs mainstream
• Instant help right in the heart of the community
• ASTRAZENEC­A SEEKS WIDER PH CLINICAL TRIAL NETWORK
• Mankind Pharma inks pact with China’s Chongqing Chenan Biopharmac­eutical
• GLP-1 boom propels pharma firms deeper into wellness, nutraceuti­cals
• Doorstep medicine delivery likely to continue
• Judge slams ‘abuse of process’ after GLP-1 ruling
• Pill for meds security
• Pharmacies choose which drugs to stock
• Countries that heavily use generic medicines
• Magnetic pulses turn cancer-friendly cells into cancer fighters
• AstraZenec­a’s breast cancer pill falls short
• Dementia drug made in UK denied on NHS
• B.C. DRUGS STRATEGY DIDN'T BEAR FRUIT: STUDY
• Trial tests radiation to reduce cancer treatment’s side effects
• We are entering a hopeful moment for the treatment of cancer
• Exercise link to longer life after cancer
• SC lens on stem cell therapy for autism